These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15093702)

  • 21. Feast or famine - are GLP-1 and ghrelin secretion intertwined?
    Djurhuus CB; Hansen TK; Holst JJ; Schmitz O
    Horm Metab Res; 2002 Jul; 34(7):353-4. PubMed ID: 12189580
    [No Abstract]   [Full Text] [Related]  

  • 22. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gastrin-releasing peptide (GRP1-27), neuromedin-C (GRP18-27), and neuromedin-B on gastrin and somatostatin secretion from the rat stomach.
    Madaus S; Schusdziarra V; Seufferlein T; Classen M
    Z Gastroenterol; 1989 Sep; 27(9):449-54. PubMed ID: 2573979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat.
    Levin F; Edholm T; Ehrström M; Wallin B; Schmidt PT; Kirchgessner AM; Hilsted LM; Hellström PM; Näslund E
    Regul Pept; 2005 Nov; 131(1-3):59-65. PubMed ID: 16040140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides.
    Rehfeld JF
    Acta Physiol (Oxf); 2011 Apr; 201(4):405-11. PubMed ID: 21392266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of nociceptin on somatostatin secretion of the isolated perfused rat stomach.
    Lippl F; Schusdziarra V; Huepgens K; Allescher HD
    Regul Pept; 2002 Jul; 107(1-3):37-42. PubMed ID: 12137964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal hormones and regulation of food intake.
    Dhillo WS; Bloom SR
    Horm Metab Res; 2004; 36(11-12):846-51. PubMed ID: 15655718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
    Holst JJ
    BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
    Holst JJ; Gromada J
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E199-206. PubMed ID: 15271645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day.
    Orskov C; Wettergren A; Holst JJ
    Scand J Gastroenterol; 1996 Jul; 31(7):665-70. PubMed ID: 8819215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrapancreatic effects of GIP and GLP-1.
    Vella A; Rizza RA
    Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine.
    Rudovich NN; Dick D; Moehlig M; Otto B; Spranger J; Rochlitz HJ; Ristow M; Tschoep M; Pfeiffer AF
    Regul Pept; 2005 Apr; 127(1-3):95-9. PubMed ID: 15680475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon receptor expression and glucagon stimulation of ghrelin secretion in rat stomach.
    Katayama T; Shimamoto S; Oda H; Nakahara K; Kangawa K; Murakami N
    Biochem Biophys Res Commun; 2007 Jun; 357(4):865-70. PubMed ID: 17462598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.